Tibsovo approved for patients with R/R AML with IDH1 mutation

Create PDF

The FDA granted approval to Abbott for the RealTime IDH1 Assay, a companion diagnostic that can be used to detect the IDH1 mutation.

Agios Pharmaceuticals, 617-649-8600